Alexander Tups

Dr. Alexander Tups


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2015 in Diabetes
Verified
Journal Article
Open access
PDF file
JBJonas Benzler
Jonas Benzler
GGGoutham K. Ganjam
Goutham K. Ganjam
DPDominik Pretz
Dominik Pretz
RORebecca Oelkrug
Rebecca Oelkrug
CKChristiane E. Koch
Christiane E. Koch
ATAlexander Tups
Alexander Tups
Metabolic inflammation in the central nervous system might be causative for the development of overnutrition-induced metabolic syndrome and related disorders, such as obesity, leptin and insulin resistance, and type 2 diabetes. Here we investigated whether nutritive and genetic inhibition of the central IκB kinase β (IKKβ)/nuclear factor-κB (NF-κB) pathway in diet-induced obese (DIO) and leptin-deficient mice improves these metabolic impairments. A known prominent inhibitor of IKKβ/NF-κB signaling is the dietary flavonoid butein. We initially determined that oral, intraperitoneal, and intracerebroventricular administration of this flavonoid improved glucose tolerance and hypothalamic insulin signaling. The dose-dependent glucose-lowering capacity was profound regardless of whether obesity was caused by leptin deficiency or high-fat diet (HFD). To confirm the apparent central role of IKKβ/NF-κB signaling in the control of glucose and energy homeostasis, we genetically inhibited this pathway in neurons of the arcuate nucleus, one key center for control of energy homeostasis, via specific adeno-associated virus serotype 2–mediated overexpression of IκBα, which inhibits NF-κB nuclear translocation. This treatment attenuated HFD-induced body weight gain, body fat mass accumulation, increased energy expenditure, and reduced arcuate suppressor of cytokine signaling 3 expression, indicative for enhanced leptin signaling. These results reinforce a specific role of central proinflammatory IKKβ/NF-κB signaling in the development and potential treatment of DIO-induced comorbidities.

16 March 2017
Verified
Book Chapter
Closed access
PDF file
ATAlexander Tups
Alexander Tups
JBJonas Benzler
Jonas Benzler
DSDomenico Sergi
Domenico Sergi
SLSharon R. Ladyman
Sharon R. Ladyman
LWLynda M. Williams
Lynda M. Williams

21 February 2021 in Journal of Neuroendocrinology
Verified
Journal Article
Closed access
PDF file
ABAlisa Boucsein
Alisa Boucsein
KKKaj Kamstra
Kaj Kamstra
ATAlexander Tups
Alexander Tups

30 November 2022 in Trends in Pharmacological Sciences
Verified
Journal Article
Closed access
GBGeke Aline Boer
Geke Aline Boer
DHDebbie L. Hay
Debbie L. Hay
ATAlexander Tups
Alexander Tups

23 November 2020 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
DPDominik Pretz
Dominik Pretz
CFChristelle Le Foll
Christelle Le Foll
MRMohammed Z. Rizwan
Mohammed Z. Rizwan
TLThomas Lutz
Thomas Lutz
ATAlexander Tups
Alexander Tups
Obesity has emerged as a major risk factor for insulin resistance leading to the development of type 2 diabetes (T2D). The condition is characterized by high circulating levels of the adipose‐derived hormone leptin and a state of chronic low‐grade inflammation. Pro‐inflammatory signaling in the hypothalamus is associated with a decrease of central leptin‐ and insulin action leading to impaired systemic glucose tolerance. Intriguingly, leptin not only regulates body weight and glucose homeostasis but also acts as a pro‐inflammatory cytokine. Here we demonstrate that increasing leptin levels (62,5 µg/kg/d, PEGylated leptin) in mice fed a high‐fat diet (HFD) exacerbated body weight gain and aggravated hypothalamic micro‐ as well as astrogliosis. In contrast, administration of a predetermined dose of a long‐acting leptin antagonist (100 µg/kg/d, PESLAN) chosen to block excessive leptin signaling during diet‐induced obesity (DIO) showed the opposite effect and significantly improved glucose tolerance as well as decreased the total number of microglia and astrocytes in the hypothalamus of mice fed HFD. These results suggest that high levels of leptin, such as in obesity, worsen HFD‐induced micro‐and astrogliosis, whereas the partial reduction of hyperleptinemia in DIO mice may have beneficial metabolic effects and improves hypothalamic gliosis.

23 May 2025 in Science Immunology
Verified
Journal Article
Closed access
LDLucia Yi Du
Lucia Yi Du
PKPramuk Keerthisinghe
Pramuk Keerthisinghe
LRLeah Rolland
Leah Rolland
YSYih Jian Sung
Yih Jian Sung
HDHannah Darroch
Hannah Darroch
CHChristopher Hall
Christopher Hall
The immune response exhibits strong circadian rhythmicity, with enhanced bacterial clearance often synchronized with an organism’s active phase. Despite providing the bulk of cellular antibacterial defense, the neutrophil clockwork is poorly understood. Here, we used larval zebrafish to explore the role of clock genes in neutrophils during infection. Per2 was required in neutrophils for reactive oxygen species (ROS) production and bacterial killing by enhancing infection-responsive expression of high-mobility group box 1a ( hmgb1a ). The Cry binding domain of Per2 was required for regulation of neutrophil bactericidal activity, and neutrophils lacking Cry1a had elevated bactericidal activity and infection-responsive hmgb1a expression. A conserved cis-regulatory element with BMAL1 and nuclear factor κB binding motifs gated infection-responsive hmgb1a expression to the light phase. Mutagenesis of the BMAL1 motif in neutrophils blunted the priming effect of light on bactericidal activity and hmgb1a expression. These findings identify a light-responsive cell-intrinsic timer that controls time-of-day variations in antibacterial activity.